/
/
/

Pharmaids Pharmaceuticals Profit & Loss

Consolidated
Standalone
Quarterly
Yearly
₹
%
Name
Net Revenue
Other Income
Total Revenue
Total Expenditure
Operating Profit
Interest Expense
PBT
Net Profit
Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022
₹4 Cr₹7 Cr₹5 Cr₹9 Cr₹7 Cr₹5 Cr₹5 Cr₹5 Cr₹5 Cr₹6 Cr₹2 L₹0₹0₹0₹0₹0₹0₹30 L
₹5 L₹10 L₹8 L₹22 L₹4 L₹7 L₹70,000₹1 L₹90,000₹12 L-₹90 L-₹26 L₹37 L₹0₹0₹0₹0₹2 L
₹4 Cr₹7 Cr₹6 Cr₹9 Cr₹7 Cr₹5 Cr₹5 Cr₹5 Cr₹5 Cr₹6 Cr-₹88 L-₹26 L₹37 L₹0₹0₹0₹0₹32 L
₹5 Cr₹8 Cr₹8 Cr₹14 Cr₹13 Cr₹9 Cr₹8 Cr₹8 Cr₹9 Cr₹11 Cr₹1 Cr₹1 Cr₹2 Cr₹9 Cr₹70 L₹54 L₹6 L₹31 L
-₹70 L-₹24 L-₹2 Cr-₹5 Cr-₹5 Cr-₹4 Cr-₹3 Cr-₹2 Cr-₹3 Cr-₹5 Cr-₹2 Cr-₹1 Cr-₹1 Cr-₹9 Cr-₹70 L-₹54 L-₹6 L₹1 L
₹60 L₹65 L₹72 L₹1 Cr₹1 Cr₹1 Cr₹49 L₹34 L₹26 L₹77 L₹0₹0₹10,000₹20,000₹0₹0₹30,000₹0
₹2 Cr-₹1 Cr-₹4 Cr-₹4 Cr-₹7 Cr-₹5 Cr-₹4 Cr-₹3 Cr-₹4 Cr-₹7 Cr-₹2 Cr-₹1 Cr-₹1 Cr-₹9 Cr-₹70 L-₹54 L-₹6 L₹90,000
₹2 Cr-₹1 Cr-₹3 Cr-₹3 Cr-₹5 Cr-₹5 Cr-₹3 Cr-₹2 Cr-₹3 Cr-₹6 Cr-₹2 Cr-₹51 L-₹1 Cr-₹6 Cr-₹71 L-₹55 L-₹14 L₹90,000

Share Price Live Stats

Open (₹)29.81
Volume (₹)2,285.00
High (₹)30.72
Upper Circuit35.76
Low (₹)29.81
Lower Circuit23.84
Prev Close29.80
52W High (₹)66.00
Price30.40
52W Low (₹)25.60

Share Market Cap & Key Ratios Overview

M.Cap (₹)105.10 Cr
Div. Yield (%)0.00
PE Ratio0.00
Debt to Equity0.44
Price to Book2.05
Book Value13.51
EPS (TTM)-1.29
Face Value10.00
ROE (%)-21.64

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Name
SUNPHARMA-ANSE
DIVISLAB-ANSE
TORNTPHARM-ANSE
ZYDUSLIFE-ANSE
CIPLA-ANSE
LAURUSLABS-ANSE
MANKIND-ANSE
DRREDDY-ANSE
AUROPHARMA-ANSE
LUPIN-ANSE
PHARMAID-XNSE
LTP
1W Low
1W High
Market cap (₹)
1853.5+18 (0.98%)
1835.50
1890.40
4,44,597Cr
9610+243 (2.59%)
9305.95
9739.85
2,55,195Cr
4985+180.75 (3.76%)
4864.80
5010
1,87,712Cr
1202+49 (4.25%)
1152
1208.20
1,17,705Cr
1397.2+25.75 (1.88%)
1364
1420.50
1,13,423Cr
2001+45.75 (2.34%)
1964.50
2054.55
1,09,481Cr
2460+142 (6.13%)
2302.30
2511.80
1,02,229Cr
1202.8+31.7 (2.71%)
1186.20
1221.60
1,00,195Cr
1711.3-23.7 (-1.37%)
1690
1739.60
98,965Cr
2090-54.7 (-2.55%)
2077
2129.85
95,939Cr
30.4+0.72 (2.43%)
29.33
30.80
105Cr

Key Highlights of Pharmaids Pharmaceuticals Ltd’s P&L

In 2026-03-31, Pharmaids Pharmaceuticals Ltd reported total revenue of ₹28.17Cr, compared with ₹19.55Cr in 2025-03-31, reflecting Pharmaids Pharmaceuticals Ltd turnover.

Depreciation was ₹2.03Cr and finance costs were ₹3.52Cr in 2026-03-31

Profit Before Tax (PBT) has been ₹-₹16.3Cr in 2026-03-31 as compared to ₹-₹17.28Cr in 2025-03-31.

Net Profit (PAT) was ₹-₹11.72Cr in 2026-03-31 compared with ₹-₹10.78Cr in 2025-03-31.

Earnings per share (EPS) were ₹-3.32 in 2026-03-31, compared with ₹-3.06 in 2025-03-31.